Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.

Also called NCT04811651

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 156 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04811651
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04811651. Randomized; quadruple masking; primary purpose treatment. Start 2021-03-15 (actual); primary completion 2024-07-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke
Acronym
UMSIS
Intervention (Biological)
Umbilical Cord-derived Mesenchymal Stem Cells
Intervention (Drug)
Placebo
Lead sponsor
General Hospital of Shenyang Military Region (class: other)

Record details

Record id
cardio:ct-nct04811651
Content hash
18c5fca2ba4e792c5b2c9e30792b0695bd3ce9eb3fabb5300f20900de1d15970